SCHEMBL3793103

SCHEMBL3793103

CC(=O)OCCCCCCCCCCc1ccc2c(c1)Nc1ccccc1S2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 13/20 0.52
GAA P10253 9/20 0.52
MAPT P10636 8/20 0.52
MEN1 O00255 6/20 0.52
KMT2A Q03164 6/20 0.52
ALOX15 P16050 3/20 0.52
SNCA P37840 2/20 0.52
CYBB P04839 2/20 0.52
NOX3 Q9HBY0 2/20 0.52
NOX4 Q9NPH5 2/20 0.52
APP P05067 1/20 0.52
LMNA P02545 3/20 0.49
TDP1 Q9NUW8 3/20 0.49
ALDH1A1 P00352 1/20 0.49
TSHR P16473 1/20 0.49
HSD17B10 Q99714 1/20 0.49
KCNH2 Q12809 1/20 0.42
BCHE P06276 2/20 0.42
ACHE P22303 2/20 0.42
POLB P06746 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3788679 0.80 NOX1 (0.46) NOX1GAAMAPTMEN1KMT2A
SCHEMBL3788676 0.80 NOX1 (0.46) NOX1GAAMAPTMEN1KMT2A
SCHEMBL7773452 0.79 NOX1 (0.50) NOX1GAAMAPTMEN1KMT2A
SCHEMBL3788839 0.79 NOX1 (0.50) NOX1GAAMAPTMEN1KMT2A
SCHEMBL7528258 0.79 NOX1 (0.50) NOX1GAAMAPTMEN1KMT2A
SCHEMBL17999681 0.79 NOX1 (0.50) NOX1GAAMAPTMEN1KMT2A
SCHEMBL31366233 0.79 NOX1 (0.50) NOX1GAAMAPTMEN1KMT2A
SCHEMBL17999668 0.78 NOX1 (0.52) NOX1GAAMAPTMEN1KMT2A
SCHEMBL2311764 0.78 NOX1 (0.52) NOX1GAAMAPTMEN1KMT2A
SCHEMBL3788167 0.77 NOX1 (0.50) NOX1GAAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10947328-B2 Polymer comprising a plurality of phenothiazine groups and methods of making the same ASCENSIA DIABETES CARE HOLDINGS AG (CH) 2021-03-16 US disclosed
US-20200255552-A1 POLYMER COMPRISING A PLURALITY OF PHENOTHIAZINE GROUPS AND METHODS OF MAKING THE SAME ASCENSIA DIABETES CARE HOLDINGS AG (CH) 2020-08-13 US disclosed
US-10662264-B2 Polymer comprising a plurality of phenothiazine groups and methods of making the same ASCENSIA DIABETES CARE HOLDINGS AG (CH) 2020-05-26 US disclosed
US-20180194877-A1 POLYMER COMPRISING A PLURALITY OF PHENOTHIAZINE GROUPS AND METHODS OF MAKING THE SAME BAYER HEALTHCARE LLC 2018-07-12 US disclosed
US-9944725-B2 Polymer comprising a plurality of phenothiazine groups and methods of making the same ASCENSIA DIABETES CARE HOLDINGS AG (CH) 2018-04-17 US disclosed
US-20170044276-A1 POLYMER COMPRISING A PLURALITY OF PHENOTHIAZINE GROUPS AND METHODS OF MAKING THE SAME BAYER HEALTHCARE LLC 2017-02-16 US disclosed
US-9505884-B2 Polymer comprising a plurality of phenothiazine groups and methods of making the same ASCENSIA DIABETES CARE HOLDINGS AG (CH) 2016-11-29 US disclosed
US-20160083519-A1 Polymer Comprising A Plurality Of Phenothiazine Groups And Methods Of Making The Same ASCENSIA DIABETES CARE HOLDINGS AG (CH) 2016-03-24 US disclosed
US-9238717-B2 Polymer comprising a plurality of phenothiazine groups and methods of making the same BAYER HEALTHCARE LLC (US) 2016-01-19 US disclosed
US-20140235797-A1 Polymer Comprising A Plurality Of Phenothiazine Groups And Methods Of Making The Same BAYER HEALTHCARE LLC (US) 2014-08-21 US disclosed
US-8742063-B2 Polymer bonded redox molecules and methods of making the same BAYER HEALTHCARE LLC (US) 2014-06-03 US disclosed
US-8283347-B2 Redox molecules and methods of making the same BAYER HEALTHCARE LLC (US) 2012-10-09 US disclosed
US-20110294959-A1 Polymer Bonded Redox Molecules And Methods Of Making The Same BAYER HEALTHCARE LLC (US) 2011-12-01 US disclosed
WO-2010141359-A2 REDOX MOLECULES AND METHODS OF MAKING THE SAME BAYER HEALTHCARE LLC (US) 2010-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255552-A1 POLYMER COMPRISING A PLURALITY OF PHENOTHIAZINE GROUPS AND METHODS OF MAKING THE SAME PAH, TYK2, PNMT NOX1 2861/4885GAA 380/4885MAPT 178/4885
US-20160083519-A1 Polymer Comprising A Plurality Of Phenothiazine Groups And Methods Of Making The Same PAH, TYK2, PNMT NOX1 2861/4885GAA 380/4885MAPT 178/4885
US-20180194877-A1 POLYMER COMPRISING A PLURALITY OF PHENOTHIAZINE GROUPS AND METHODS OF MAKING THE SAME PAH, TYK2, PNMT NOX1 2861/4885GAA 380/4885MAPT 178/4885
US-10947328-B2 Polymer comprising a plurality of phenothiazine groups and methods of making the same PAH, TYK2, PNMT NOX1 2861/4885GAA 380/4885MAPT 178/4885
US-20170044276-A1 POLYMER COMPRISING A PLURALITY OF PHENOTHIAZINE GROUPS AND METHODS OF MAKING THE SAME PAH, TYK2, PNMT NOX1 2861/4885GAA 380/4885MAPT 178/4885
US-10662264-B2 Polymer comprising a plurality of phenothiazine groups and methods of making the same PAH, TYK2, PNMT NOX1 2861/4885GAA 380/4885MAPT 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.